Supplements

Green tea: tea versus concentrated extracts, catechins and EGCG, weight and cancer claims, liver-injury evidence, and a nadolol interaction

6 sources · Latest source check 2026-10-09 UTC

On this page

Brewed green tea and concentrated extracts are different exposures. Cancer prevention remains unproven, and weight effects are generally small or uncertain. Extracts can cause liver injury and some green-tea exposures can interact with medicines. An antioxidant mechanism cannot establish a net health benefit or certify concentrated-product safety.[1]

Tea terms identify different substances and preparations

Tea terms identify different substances and preparations
Term	Meaning
Camellia sinensis	The plant used for green, black and oolong tea.[1]
Catechins	A group of tea polyphenols; EGCG is one member.[2]
EGCG	Epigallocatechin gallate, rather than total extract mass.[2]
Tea versus extract	Ordinary drinks and concentrated supplemental products differ.[1]

Green, black and oolong teas differ in processing

EFSA describes green tea processing as preventing oxidation of polyphenols; black tea processing permits extensive enzymatically catalyzed oxidation, and oolong involves partial oxidation. The term “fermentation” in its tea description refers to this oxidation process. It should not automatically be read as a claim about probiotic microbes or microbial fermentation.[2]

An extract amount does not identify its EGCG amount

Product mass, catechin content and EGCG content are different measurements. Extract concentration and consumption pattern can differ from an infusion. Comparing equal milligrams of extract and EGCG therefore compares different exposures. EFSA’s defined ingredient quantities should retain their units and preparation context.[2]

The safety assessment did not establish a universal threshold

EFSA reported increased serum transaminases in intervention studies using supplements at or above 800 mg EGCG per day. It also discussed reports involving lower exposures and preparation differences. Its 2018 opinion could not identify an extract amount considered safe; ordinary infusion history cannot certify supplement safety.[2]

The selected pooled weight result was close to no difference

Six studies outside Japan yielded a mean weight difference of −0.04 kg, with a 95% interval from −0.5 to +0.4 kg. Results from Japanese studies differed too much to pool in the same way. Maintenance studies did not demonstrate benefit. The review described the overall weight effect as too small to be clinically important.[3]

Cancer incidence and mortality were distinct review questions

Developing cancer, dying from cancer, quality of life and liver-enzyme changes are different outcomes. A favorable association in one cannot settle all the others. Full contemporary update, trial-level bias and preparation appraisal remain pending; this page does not assign an independent Atlas certainty grade.[4]

Liver abnormalities occurred more often with extract

Twenty-six extract recipients, 5.1%, developed moderate or more severe liver-test abnormalities. The estimated odds ratio was 7.0, with a 95% interval of 2.4–20.3. Liver tests improved after withdrawal and sometimes rose again with re-exposure. That pattern strengthens the suspected product relationship, but it is not a reason to deliberately repeat exposure.[5]

Even a drink can have a medicine interaction

Misaka and colleagues’ 2014 study involved ten healthy volunteers receiving nadolol with green tea or water after fourteen days of repeated beverage consumption. Green tea reduced measured nadolol peak concentration and overall exposure by about 85%, and reduced its measured systolic-pressure effect. This was a small pharmacokinetic study, rather than a long-term clinical event trial.[6]

The transporter experiment supports a mechanism with limits

Separate cell uptake assays supported inhibition of intestinal OATP1A2-mediated nadolol uptake as a possible explanation. Human concentration findings and cell-mechanism findings should retain their separate settings. They cannot establish the same magnitude of interaction for every tea, medicine or individual, or determine a reliable personal spacing interval.[6]

Caffeine, extracts and topical medicinal products need separate context

NCCIH describes caffeine-related concerns for beverages, digestive effects with extracts, and uncommon liver injury mainly involving supplemental extracts. It also identifies medication-interaction concerns. Prescription topical green-tea-derived preparations for genital warts are a distinct route and indication; that use cannot establish oral cancer prevention. Pregnancy, breastfeeding and individual medicine combinations require their own evidence.[1]

Evidence & uncertainty

EFSA found liver-enzyme elevations with high-exposure supplements and could not identify a safe extract amount. Its 800 mg EGCG finding is not a universal safety boundary.[2]

Selected-source overview · Independent review pending

Published questions

Are brewed green tea and concentrated green tea extracts equivalent exposures?

Selected-source overview · Independent review pending. Read the evidence context.

Their composition and exposure differ.[1]

Evidence behind this answer

Green Tea: Usefulness and Safety
agency condition or prevention explanation · Date not stated
Selected relevant original official page passages inspected · Tea identity, beverage/extract and topical distinctions, caffeine, liver and interaction concerns